Goldberg SB

Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, USA.

21 papers · 2 preprints · ORCID

ArticlePsychedelics

Politically Salient Events May Modulate Effects of Naturalistic Psychedelic Use on Support for Partisan Violence.

Simonsson O, Hendricks PS, Osika W +1

Europe PMC2026
PreprintLSD

Child and maternal health outcomes following antenatal exposure to classic psychedelic substances: a systematic review

Sun S, Hanson C, Hendricks PS +9

Europe PMC2026
ArticlePsychedelics

Prevalence, types, and demographic characteristics associated with major life changes following psychedelic use.

Carlisle NA, Simonsson O, MacCarthy S +5

Europe PMC2026
ArticlePsychedelics

The Promises and Pitfalls of Psychedelic Use Among Religious Leaders.

Simonsson O, Goldberg SB

Europe PMC2025
ArticlePsilocybin

Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.

Olofsson M, Osika W, Goldberg SB +6

Europe PMC2026
ArticlePsychedelics

Naturalistic psychedelic use and changes in depressive symptoms.

Simonsson O, Hendricks PS, Swords CM +2

Europe PMC2025
ArticlePsychedelics

Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms.

Simonsson O, Goldberg SB, Osika W +5

Europe PMC2025
ArticlePsychedelics

Associations between psychedelic-related and meditation-related variables: A longitudinal study.

Simonsson O, Chaturvedi S, Hendricks PS +5

Europe PMC2025
ArticleDMT

Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.

Jiwani Z, Goldberg SB, Stroud J +7

Europe PMC2025
ArticlePsychedelics

Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies.

Simonsson O, Goldberg SB, Hendricks PS

Europe PMC2025
PreprintDMT

Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors

Jiwani Z, Goldberg SB, Stroud J +7

Europe PMC2024
ArticlePsychedelics

Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.

Honk L, Stenfors CUD, Goldberg SB +6

Europe PMC2024
ArticlePsilocybin

Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.

Simonsson O, Hendricks PS, Stenfors CU +3

Europe PMC2024
ArticlePsychedelics

Psychedelic use and psychiatric risks.

Simonsson O, Goldberg SB, Chambers R +3

Europe PMC2025
ArticlePsilocybin

Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.

Simonsson O, Osika W, Stenfors CUD +3

Europe PMC2024
ArticlePsilocybin

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.

Simonsson O, Carlbring P, Carhart-Harris R +5

Europe PMC2023
ArticlePsilocybin

Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.

Simonsson O, Stenfors CUD, Goldberg SB +2

Europe PMC2023
ArticlePsilocybin

Classic psychedelic use and current meditation practice.

Simonsson C, Chambers R, Hendricks PS +6

Europe PMC2023
ArticlePsilocybin

Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.

Simonsson O, Hendricks PS, Chambers R +2

Europe PMC2023
ArticlePsilocybin

Classic psychedelics, health behavior, and physical health.

Simonsson O, Hendricks PS, Chambers R +2

Europe PMC2022
ArticlePsilocybin

Prevalence and associations of classic psychedelic-related seizures in a population-based sample.

Simonsson O, Goldberg SB, Chambers R +3

Europe PMC2022
ArticlePsilocybin

Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.

Simonsson O, Goldberg SB

Europe PMC2023
ArticlePsilocybin

Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.

Goldberg SB, Shechet B, Nicholas CR +4

Europe PMC2020